Stock trades at 22.6x P/E trailing. Management guiding for doublin revenues in 3 years. While EBITDA margins are expected to improve further to be in the range of 25%-26% (from 23% in FY23).
Company continues to be net cash with 33% RoE
| Subscribe To Our Free Newsletter |
